Prolactinomas Resistant to Dopamine Agonists: Pathophysiology and Treatment
I Shimon - Archives of Medical Research, 2023 - Elsevier
Prolactinomas are the most common functional pituitary tumors, accounting for 40% of all
pituitary adenomas. Medical treatment with dopamine agonists (DA), mainly cabergoline, is …
pituitary adenomas. Medical treatment with dopamine agonists (DA), mainly cabergoline, is …
Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment
L Dzialach, J Sobolewska, Z Zak… - Frontiers in …, 2024 - frontiersin.org
Prolactinomas (PRLomas) constitute approximately half of all pituitary adenomas and
approximately one-fifth of them are diagnosed in males. The clinical presentation of …
approximately one-fifth of them are diagnosed in males. The clinical presentation of …
Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors
AL Lin, VA Rudneva, AL Richards, Y Zhang… - Acta …, 2024 - Springer
Pituitary neuroendocrine tumors (PitNETs) exhibiting aggressive, treatment-refractory
behavior are the rare subset that progress after surgery, conventional medical therapies …
behavior are the rare subset that progress after surgery, conventional medical therapies …